Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells - Hu, Wei-Bin; Liu, Yi-Ting; Li, Jing; Wang, Ying; Sun, Xuan-Zi; Hua, Ming-Yu; Liu, Xue-Ting; Hui, Bei-Na (Toxicology in vitro, 2024)
Keywords: AKT/GSK3β; ER stress; Esophageal cancer; Pristimerin; ROS; ER stress; Pristimerin; Esophageal cancer; ROS; AKT/GSK3β